Ruffo Frank

Chief Financial Officer at ACRS

Sold, on record
$2.9M
Dollars the filings state
Form 4 sales
4
Latest Mar 10, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ACRSAclaris Therapeutics, Inc.Chief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ACRSUnusual
    Apr 26, 2021 2021

    Sold 87,339 shares at $26.45 ($2.3M)

    Ruffo Frank, Chief Financial Officer

    Sold 36.5% of holdings ($6.3M position)151,720 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ACRSPlan not stated
    Jun 2, 2021 +37 days

    Sold 15,037 shares at $21.64 ($325k)

    Ruffo Frank, Chief Financial Officer

    Sold 8.1% of holdings ($4M position)169,872 shares leftFiling

  3. 3 Form 4 sale ACRSPlan not stated
    Feb 9, 2022 +252 days

    Sold 1,388 shares at $12.66 ($18k)

    Ruffo Frank, Chief Financial Officer

    Sold 0.8% of holdings ($2.2M position)172,359 shares leftFiling

  4. 4 Form 4 sale ACRSPlan not stated
    Mar 10, 2022 +29 days

    Sold 12,823 shares at $15.55 ($199k)

    Ruffo Frank, Chief Financial Officer

    Sold 6% of holdings ($3.3M position)201,883 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Ruffo Frank
Source
Mar 10, 2022Mar 14, 2022ACRSChief Financial OfficerForm 4 sale12,823$199k6.0%Plan not statedSEC
Feb 9, 2022Feb 11, 2022ACRSChief Financial OfficerForm 4 sale1,388$18k0.8%Plan not statedSEC
Jun 2, 2021Jun 2, 2021ACRSChief Financial OfficerForm 4 sale15,037$325k8.1%Plan not statedSEC
Apr 26, 2021Apr 26, 2021ACRSChief Financial OfficerForm 4 sale87,339$2.3M36.5%UnusualSEC